References
- AraiHOuchiYYokodeMMembers of the Subcommittee for Aging. Toward the realization of a better aged society: messages from gerontology and geriatricsGeriatr Gerontol Int2012121162222188494
- Alvarez-SabinJRomanGCCiticoline in vascular cognitive impairment and vascular dementia after strokeStroke201142Suppl 1S404321164117
- Garcia-CobosRFrank-GarciaAGutierrez-FernandezMDiez-TejedorECiticoline, use in cognitive decline: vascular and degenerativeJ Neurol Sci20102991–218819220875651
- HurtadoOLizasoainIMoroMANeuroprotection and recovery: recent data at the bench on citicolineStroke201142Suppl 1S333521164125
- TeatherLAWurtmanRJDietary cytidine (5′)-diphosphocholine supplementation protects against development of memory deficits in aging ratsProg Neuropsychopharmacol Biol Psychiatry200327471171712787861
- SecadesJJCiticoline: pharmacological and clinical review, 2010 updateRev Neurol201152Suppl 2S16221432836
- FioravantiMYanagiMCytidinediphosphocholine (CDP-choline) for cognitive and behavioural disturbances associated with chronic cerebral disorders in the elderlyCochrane Database Syst Rev20052CD00026915846601
- ZafonteRFriedewaldWTLeeSMThe citicoline brain injury treatment (COBRIT) trial: design and methodsJ Neurotrauma200926122207221619803786
- CaamanoJGómezMJFrancoACacabelosREffects of CDP-choline on cognition and cerebral hemodynamics in patients with Alzheimer’s diseaseMethods Find Exp Clin Pharmacol19941632112187913981
- AlvarezXAMouzoRPichelVDouble-blind placebo-controlled study with citicoline in APOE genotyped Alzheimer’s disease patients. Effects on cognitive performance, brain bioelectrical activity and cerebral perfusionMethods Find Exp Clin Pharmacol199921963364410669911
- SecadesJJAlvarez-SabínJRubioFLozanoRDavalosACastilloJTrial InvestigatorsCiticoline in intracerebral haemorrhage: a double-blind, randomized, placebo-controlled, multi-centre pilot studyCerebrovasc Dis2006215–638038516490951
- ChoHJKimYJEfficacy and safety of oral citicoline in acute ischemic stroke: drug surveillance study in 4,191 casesMethods Find Exp Clin Pharmacol200931317117619536360
- ArciniegasDBAndersonCATopkoffJMcAllisterTWMild traumatic brain injury: a neuropsychiatric approach to diagnosis, evaluation, and treatmentNeuropsychiatr Dis Treat20051431132718568112
- CacabelosRAlvarezXAFranco-MasideAFernandez-NovoaLCaamanoJEffect of CDP-choline on cognition and immune function in Alzheimer’s disease and multi-infarct dementiaAnn N Y Acad Sci19936953213238239305
- CacabelosRAlvarezXAFranco-MasideAFernandez-NovoaLCaamanoJTherapeutic effects of CDP-choline in Alzheimer’s disease. Cognition, brain mapping, cerebrovascular hemodynamics, and immune factorsAnn N Y Acad Sci19967773994038624120
- RankinJCerebral vascular events in patients over the age of 60. II: PrognosisScott Med J19572520021513432835
- van SwietenJCKoudstaalPJVisserMCSchoutenHJvan GijnJInterobserver agreement for the assessment of handicap in stroke patientsStroke19881956046073363593
- SulterGSteenCDe KeyserJUse of the Barthel Index and modified Rankin Scale in acute stroke trialsStroke19993081538154110436097
- LydenPBrottTTilleyBImproved reliability of the NIH Stroke Scale using video training. NINDS TPA Stroke Study GroupStroke19942511222022267974549
- MuirKWWeirCJMurrayGDPoveyCLeesKRComparison of neurological scales and scoring systems for acute stroke prognosisStroke19962710181718208841337
- KasnerSEChalelaJALucianoJMReliability and validity of estimating the NIH stroke scale score from medical recordsStroke19993081534153710436096